Generation and characterization of the binding epitope of a novel monoclonal antibody to sulfatide (sulfogalactosylceramide) OL-2: Applications of antigen immunodetections in brain tissues and urinary samples

Journal of Neuroimmunology

Volumn 193, Issue 1-2, 2008, Pages 52-58

  Colsch, Benoit ^a,b   Baumann, Nicole ^a,b   Ghandour, M Said ^c  

^a Centre National de la Recherche Scientifique   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Université de Strasbourg Faculté de Psychologie   (France)

Author keywords

Brain lipids; Immunodetection; Monoclonal antibody; Sulfatide; Urine lipids

Indexed keywords

CERAMIDE DERIVATIVE; CERAMIDE SULFOGALACTOSIDE; EPITOPE; GLYCOLIPID; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY OL 2; SULFATIDE; SULFOGALACTOSYLSPHINGOSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIGEN DETECTION; ARTICLE; BRAIN TISSUE; CELL LINE; CONTROLLED STUDY; IMMUNODETECTION; LEUKODYSTROPHY; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; SPLEEN CELL; THIN LAYER CHROMATOGRAPHY; WHITE MATTER;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; BRAIN CHEMISTRY; CHROMATOGRAPHY, THIN LAYER; EPITOPES; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKODYSTROPHY, METACHROMATIC; RATS; SULFOGLYCOSPHINGOLIPIDS;

EID: 37749009191     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.10.008     Document Type: Article

References (41)

1. Andersson K., Buschard K., Fredman P., Kaas A., Lidstrom A.M., Madsbad S., Mortensen H., and Mansson J.E. Patients with insulin-dependent diabetes but not those with non-insulin-dependent diabetes have anti-sulfatide antibodies as determined with a new ELISA assay. Autoimmunity 35 (2002) 463-468
2. Bansal R., Stefansson K., and Pfeiffer S.E. Proligodendoblast antigen (POA), a developmental antigen expressed by A007/O4-positive oligodendrocyte progenitors prior to the appearance of sulfatide and galactocerebroside. J. Neurochem. 58 (1992) 2221-2229
3. Bansal R., Warrington A.E., Gard A.L., Ranscht B., and Pfeiffer S.E. Multiple and novel specificities of monoclonal antibodies 01, 04 and R-mAb used in the analysis of oligodendrocyte development. J. Neurosci. Res. 24 (1989) 548-557
4. Bansal R., Winkler S., and Bheddah S. Negative regulation of oligodendrocyte differentiation by galactosphingolipids. J. Neurosci. Res. 19 (1999) 7913-7924
5. Baumann N., Turpin J.C., Lefevre M., and Colsch B. Motor and psycho-cognitive clinical types in adult metachromatic leukodystrophy: genotype/phenotype relationships?. J. Physiol. 96 (2002) 301-306 (Paris)
6. BenYounes-Chennoufi A., Leger J.M., Hauw J.J., Preud'homme J.L., Bouche P., Aucouturier P., Ratinahirana H., Lubetzki C., Lyon-Caen O., and Baumann N. Ganglioside GD1b is the target antigen for a biclonal IgM in a case of sensory-motor axonal polyneuropathy: involvement of N-Acetyl neuraminic acid in the epitope. Ann. Neurol. 32 (1992) 18-23
7. Bodennec J., Koul O., Aguado L., Brichon G., Zwingelstein G., and Portoukalian J.A. procedure for fractionation of sphingolipid classes by solid-phase extraction on aminopropyl cartridges. J. Lipid Res. 41 (2000) 1524-1531
8. Burkart T., Caimi L., Herschkowitz N.N., and Wiesmann U.N. Metabolism of sulfogalactosyl glycerolipids in the myelinating mouse brain. Dev. Biol. 98 (1983) 182-186
9. Chevalier R., Colsch B., Afonso C., Baumann N., Tabet J.C., and Mallet J.M. Synthetic sulfated glucuronosyl paragloboside (SGPG) and its use for the detection of autoimmune peripheral neuropathies. Tetrahedron. 62 (2006) 563-577
10. Coetzee T., Suzuki K., and Popko B. New perspectives on the function of myelin galactolipids. TINS 21 (1998) 126-130
11. Dabby R., Weiner L.H., Hays A.P., Olarte M., and Latov N. Antisulfatide antibodies in neuropathy: clinical and electrophysiological correlates. Neurology 54 (2000) 1448-1452
12. Dittmer J.C., and Lester R.L. A simple, specific spray for the detection of phospholipids on thin-layer chromatograms. J Lipid Res. 15 (1964) 126-127
13. Fewster M.E., Burns B.J., and Mead J.F. Quantitative densitometric thin-layer chromatography of lipids using copper acetate reagent. J. Chromatogr. 43 (1969) 120-126
14. Folch J., Lees M., and Sloane-Stanley S. A simple method for the isolation and purification of total lipid from animal tissues. J. Biol. Chem. 226 (1957) 497-509
15. Fredman P., Magnani J.L., Nirenberg M., and Ginsburg V. Monoclonal antibody A2B5 reacts with many gangliosides in neuronal tissue. Arch. Biochem. Biophys. 233 (1994) 661-666
16. Fredman P., Mansson J.E., Rynmark B.M., Josefsen K., Ekblond A., Halldner L., Osterbye T., Horn T., and Buschard K. The glycosphingolipid sulfatide in the islets of Langerhans in rat pancreas is processed through recycling: possible involvement in insulin trafficking. Glycobiology 10 (2000) 39-50
17. Fredman P., Mattsson L., Andersson K., Davidsson P., Ishizuka I., Jeansson S., Mansson J.E., and Svennerholm L. Characterization of the binding epitope of a monoclonal antibody to sulphatide. Biochem. J. 251 (1988) 17-22
18. Fujimoto H., Tadano-Aritomi K., Tokumasu A., Ito K., Hikita T., Suzuki K., and Ishizuka I. Requirement of seminolipid in spermatogeneis revealed by UDP-galactose:ceramide galactosyltransferase-deficient mice. J. Biol. Chem. 275 (2000) 22623-22626
19. Galfre G., Howe S.C., Milstein C., Butcher G.W., and Howard J.C. Antibodies to major histocompatibility antigens produced by hybrid cell lines. Nature 266 (1977) 550-552
20. Guchhait P., Lopez J.A., and Thiagaran P. Characterization of autoantibodies against sulfatide from a V-gene pahe display library derived from patients with systemic lupus erythematosus. J. Immunol. Meth. 295 (2004) 129-137
21. Harpin M.L., Coulon-Morelec M.J., Yeni P., Danon F., and Baumann N. Direct sensitive immunocharacterization of gangliosides on plastic thin-layer plates using peroxidase staining. J. Immunol. Meth. 78 (1985) 135-141
22. Hirahara Y., Bansal R., Honke K., Ikenaka K., and Wada Y. Sulfatide is a negative regulator of oligodendrocyte differentiation: development in sulfatide-null mice. Glia 45 (2004) 269-277
23. Honke K., Hirahara Y., Dupree J., Suzuki K., Popko B., Fukushima K., Fukushima J., Nagasawa T., Yoshida N., Wada Y., and Taniguchi N. Paranodal junction formation and spermatogenesis require sulfoglycolipids. Proc Natl Acad Sci (USA) 99 (2002) 4227-4232
24. Ilyas A.A., Chen Z.W., and Cook S.D. Antibodies to sulfatide in cerebrospinal fluid of patients with multiple sclerosis. J. Neuroimmunol. 139 (2003) 76-80
25. Isaac G., Pernber Z., Gieselmann V., Hansson E., and Mansson J.E. Sulfatide with short chain fatty acid dominates in astrocytes and neurons. FEBS J 273 (2006) 1782-1790
26. Ishizuka I. Chemistry and functional distribution of sulfoglycolipids. Prog. Lipid Res. 36 (1997) 245-319
27. Kanter J.I., Narayana S., Ho P.P., Catz I., Warren K.G., Sobel R.A., Steinman L., and Robinson W.H. Lipid microarrays identify key mediators of autoimmune brain inflammation. Nature Medicine 12 (2006) 138-143
28. Kohler G., and Milstein C. Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. Eur. J. Immunol. 6 (1976) 511-519
29. Korey S.R., Gomez C.J., Stein A., Gonatas J., Suzuki K., Terry R.D., and Weiss M. Studies in Tay Sachs disease. I. A. Methods. J. Neuropathol. Exp. Neurol. 22 (1963) 2-9
30. Levine M., Kornblatt M.J., and Murray R.K. Isolation and partial characterization of a sulfogalactoglycerolipid from rat brain. Canad. J. Biochem. 53 (1975) 679-689
31. Lopate G., Pestronk A., Evans S., Li L., and Clifford D. Anti-sulfatide antibodies in HIV-infected individuals with sensory neuropathy. Neurology 64 (2005) 1632-1634
32. Lugowska A., Tylki-Szymanska A., Berger J., and Molzer B. Elevated sulfatide excretion in compound heterozygotes of metachromatic leukodystrophy and ASA-pseudodeficiency allele. Clin. Biochem. 30 (1997) 325-331
33. Mailly P., Ben Younes-Chennoufi A., and Bon S. The monoclonal antibodies Elec-39, HNK-1 and NC-1 recognize common structures in the nervous system and muscles of vertebrates. Neurochem. Int. 15 (1989) 517-530
34. Majocha R.E., Jungalwala F.B., Rodenrys A., and Marotta C.A. Monoclonal antibody to embryonic CNS antigen A2B5 provides evidence for the involvement of membrane components at sites of Alzheimer degeneration and detects sulfatides as well as gangliosides. J. Neurochem. 53 (1989) 953-961
35. Neskovic N.M., Sarlieve L.L., and Mandel P. Biosynthesis of glycolipids in myelin deficient mutants: brain glycosyl transferases in jimpy and quaking mice. Brain Res. 42 (1972) 147-157
36. Pernber Z., Molander-Melin M., Berthold C.H., Hansson E., and Fredman P. Expression of the myelin and oligodendrocyte progenitor marker sulfatide in neuron and astrocytes of adult rat brain. J Neurosci. Res. 69 (2002) 86-93
37. Rafi M.A., Coppola S., Liu S.L., Rao H.Z., and Wenger D.A. Disease-causing mutations in cis with the common arylsulfatase A pseudo-deficiency allele compound the difficulties in accurately identifying patients and carriers of metachromatic leukodystrophy. Molec. Gen. Metab. 79 (2003) 83-90
38. Rauschka R., Colsch B., Baumann N., Wevers R., Schmidbauer M., Krammer M., Turpin J.C., Lefevre M., Olivier C., Tardieu S., Krivit W., Moser H., Moser A., Gieselmann V., Zalc B., Cox T., Reuner U., Tylki-Szymanska A., Aboul-Enein F., Leguern E., Bernheimer H., and Berger J. Late onset metachromatic leukodystrophy: genotype strongly influences phenotype. Neurology 67 (2006) 859-863
39. Rosenbluth J., Schiff R., Liang W.L., and Dou W. Antibody-mediated CNS demyelination II. Focal spinal cord lesions induced by implantation of an IgM antisulfatide-secreting hybridoma. J. Neurocytol. 32 (2003) 265-276
40. Uyama E.I., Kutsukake Y., Hara A., Uemura K., Uchino M., Mita S., Ando M., and Taketomi T. Abnormal excretion of urinary phospholipids and sulfatide in patients with mitochonrial encephalopathies. Biochem. Biophys. Res. Commun. 194 (1993) 266-273
41. Williams M.A., and McCluer R.H. The use of sep-pack C18 cartridge during the isolation of gangliosides. J. Neurochem 35 (1980) 266-269